Live from the Markets: Vivendi on the cutting edge, Crédit Agricole counterattacks and marriage in advertising

In France

Important announcements (and less important… I should point out that the information is given immediately before the opening and does not prejudge the color of the shares during the session)

• Vivendi shareholders vote on the split today, with one vote per spun-off entity and a two-thirds majority required for the first two splits.
• UniCredit ready to discuss Banco BPM with Crédit Agricole, which holds nearly 15.1% of the capital.
• Stellantis intends to return to the European automobile lobby.
• Alstom will supply 35 additional RER NG trainsets for the RER E line of the Île-de-France Mobilités network.
• Sanofi's rilzabrutinib for ITP showed positive results in the Phase III Luna 3 study.
• Allianz and Amundi have stopped discussions on the merger of their asset management activities.
• JCDecaux wins the contract for bus shelters in Rome in Italy.
• BioMérieux authorized to market its test for tropical fevers in the United States.
• Axway becomes 74Software (the mnemonic will change to “74SW” on December 12).
• Clariane obtains the renewal of its revolving credit line of €492.5 million for 6 months.
• Atos fell 98%, to less than a euro cent, on Friday (surprise!).
• Ekosport, supported by IDI, accelerates its European expansion with the acquisition of Dutch pure-player SkiWebShop.
• Spineway has changed its financial director.
• Crossject and the US Department of Defense are resuming their cooperation on research on needle-free auto-injectors.
• The main publications of the day : Poxel… The rest here.

In the big world

Important (and not so important) announcements

D’Europe

• Generali hopes to reach a preliminary agreement on the main terms of an asset management deal with Natixis IM before its investor day on January 30, 2025, Bloomberg reported.
• CVC has its sights set on CompuGroup, according to Bloomberg.
• Boliden acquires the Neves-Corvo mines in Portugal and Zinkgruvan in Sweden from Lundin Mining for $1.3 billion.
• Volkswagen and its employees clash in the latest round of negotiations over factory closures.
• Equinor is withdrawing from Nigeria by selling its assets to the public company Chappal Energies for $1.2 billion.
• AstraZeneca announced positive results from its Phase 3 trial of a new combination formulation for the treatment of leukemia.
• Bâloise appoints the representative of an activist investor to the board of directors.
• The acquisition of Catalent by Novo Holdings (holding company of Novo Nordisk) receives the antitrust green light from the EU.
• Genmab's Chronic Lymphocytic Leukemia Antibody Shows High Phase Ib/2 Response Rates.
• The main publications of the day : nothing…

From North America

• Omnicom and The Interpublic are discussing a merger, according to Bloomberg.
• Boeing's top lobbyist is leaving the plane maker.
• Super Micro Computer gets additional time to file its delayed annual report.
• Palantir and Anduril sign a partnership for AI training in the field of defense.
• Newmont is selling its Cripple Creek & Victor operation in Colorado to SSR Mining for up to $275 million.
• Chevron CEO says there have been no discussions with President-elect Trump on Venezuela.
• The main publications of the day : nothing…

From Asia Pacific and beyond

• BYD is on pace to exceed its 2024 sales target, and could even surpass Ford and Honda in terms of sales figures.
• VinFast (Vingroup) will build a second production plant in Vietnam.
• Kioxia launches its IPO at 1,455 yen per share.
• Xiaomi plans to launch a third vehicle model in 2026.
• Sonic Healthcare buys a German laboratory for 423 million euros.
• The main publications of the day : …

The rest of the global publications calendar here.

Lectures